Exact Mass: 434.2933

beta-Citraurol

C30H42O2 (434.3185)

beta-Citraurol is found in citrus. beta-Citraurol is a constituent of citrus hybrid peel Constituent of citrus hybrid peel. beta-Citraurol is found in citrus.

(12S,15S)-15-O-Demethyl-10,29-dideoxy-11,12-dihydro-striatin C

C25H38O6 (434.2668)

(12S,15S)-15-O-Demethyl-10,29-dideoxy-11,12-dihydro-striatin C is found in mushrooms. (12S,15S)-15-O-Demethyl-10,29-dideoxy-11,12-dihydro-striatin C is a constituent of Hericium erinaceum (lions mane)

Polysorbate 60

C22H42O8 (434.288)

Polysorbate 60 is an emulsifier, opacifier, protective coating, dough conditioner, dispersant, wetting agent, stabiliser, defoamer, poultry scald agent, flavour.Polysorbates are a class of emulsifiers used in some pharmaceuticals and food preparation. They are often used in cosmetics to solubilize essential oils into water-based products. Polysorbates are oily liquids derived from PEG-ylated sorbitan (a derivative of sorbitol) esterified with fatty acids. (Wikipedia). Emulsifier, opacifier, protective coating, dough conditioner, dispersant, wetting agent, stabiliser, defoamer, poultry scald agent, flavour.

Butyl oleate sulfate

C22H42O6S (434.2702)

Surfactant. Butyl oleate sulfate is used in dehydration of grapes to produce raisins and as a coating for citrus fruits. Surfactant. It is used in dehydration of grapes to produce raisins and as a coating for citrus fruits

Erinacine C

C25H38O6 (434.2668)

Erinacine C is found in mushrooms. Erinacine C is a metabolite of Hericium erinaceum (lions mane).

24-Fluorocalcitriol

C27H43FO3 (434.3196)

Kaspar

C26H34N4O2 (434.2682)

Urea, N-butyl-N'-(2-(3-(5-ethyl-4-phenyl-1H-imidazol-1-yl)propoxy)-6-methylphenyl)-

C26H34N4O2 (434.2682)

Ribociclib

C23H30N8O (434.2542)

L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EF - Cyclin-dependent kinase (cdk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent

MG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/0:0)

C25H38O6 (434.2668)

MG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

MG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/0:0)

C25H38O6 (434.2668)

MG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

MG(0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

C25H38O6 (434.2668)

MG(0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

MG(0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C25H38O6 (434.2668)

MG(0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

DG(2:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C25H38O6 (434.2668)

DG(2:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/2:0/0:0)

C25H38O6 (434.2668)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C25H38O6 (434.2668)

DG(2:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/2:0)

C25H38O6 (434.2668)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C25H38O6 (434.2668)

DG(2:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/2:0/0:0)

C25H38O6 (434.2668)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C25H38O6 (434.2668)

DG(2:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/2:0)

C25H38O6 (434.2668)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C25H38O6 (434.2668)

DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/2:0/0:0)

C25H38O6 (434.2668)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C25H38O6 (434.2668)

DG(2:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/2:0)

C25H38O6 (434.2668)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C25H38O6 (434.2668)

DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/2:0/0:0)

C25H38O6 (434.2668)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C25H38O6 (434.2668)

DG(2:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/2:0)

C25H38O6 (434.2668)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C25H38O6 (434.2668)

DG(2:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/2:0/0:0)

C25H38O6 (434.2668)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C25H38O6 (434.2668)

DG(2:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/2:0)

C25H38O6 (434.2668)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C25H38O6 (434.2668)

DG(2:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/2:0/0:0)

C25H38O6 (434.2668)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C25H38O6 (434.2668)

DG(2:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/2:0)

C25H38O6 (434.2668)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Rasfonin

C25H38O6 (434.2668)

N,N-Didemethylalfileramine

C28H38N2O2 (434.2933)

Clibadic acid

C25H38O6 (434.2668)

3beta-Malonyloxy-15-acetoxy-ent-labda-7,13E-dien methylester

C25H38O6 (434.2668)

Dictamnoside J

C21H38O9 (434.2516)

Iriomoteolide 3a

C25H38O6 (434.2668)

alpha-Citraurinol

C30H42O2 (434.3185)

Stolonic acid A

C26H42O5 (434.3032)

Stereonsteroid I

C26H42O5 (434.3032)

8,8-Bis(7-hydroxycalamenene)

C30H42O2 (434.3185)

Bicalamenene

C30H42O2 (434.3185)

Philadelphinone

C25H38O6 (434.2668)

Plagiospirolide E

C30H42O2 (434.3185)

Myltaylorione A

C30H42O2 (434.3185)

Myltaylorione B

C30H42O2 (434.3185)

Vladimuliecin A

C25H38O6 (434.2668)

SER-601

C28H38N2O2 (434.2933)

methyl 2-(9-(cyclohexylmethyl)-9H-carbazole-3-carboxamido)-3,3-dimethylbutanoate

C27H34N2O3 (434.2569)

ASB-14

C22H46N2O4S (434.3178)

C30H42O2

C30H42O2 (434.3185)

12-angeloxy-8-O-angeloylshiromodiol

C25H38O6 (434.2668)

Citrullonol

C30H42O2 (434.3185)

C26H42O5

C26H42O5 (434.3032)

1alpha-(beta-D-glucopyranosyloxy)eudesma-3alpha,4beta,11-triol

C21H38O9 (434.2516)

9,10-diangeloyloxy-11-hydroxy-10,11-dihydrobrickelliol

C25H38O6 (434.2668)

tingenone

C29H38O3 (434.2821)

6alpha-isobutyryloxy-7beta-acetoxy-13-Z-kolavenic acid

C26H42O5 (434.3032)

Tri-Ac-(3beta,5alpha,16alpha,17alpha)-Androstane-3,16,17-triol

C25H38O6 (434.2668)

methyl rel-(1R,2S)-(1-farnesyl-2-hydroxy-4-oxocyclopentan-1-yl)-3-ethoxypropanoate

C26H42O5 (434.3032)

18,19-Dihydrousambarensine

C29H30N4 (434.247)

15-(3-Hydroxy-2-methylbutanoyl)-(ent-15beta)-9, 15-Dihydroxy-16-kauren-19-oic acid

C25H38O6 (434.2668)

6alpha,8alpha-dihydroxy-23-carboxy-labd-13(14),17-dien-16,19-olide

C25H38O6 (434.2668)

Tingitanol

C25H38O6 (434.2668)

(3beta, 5alpha, 22R, 23S)-22-Chlorocholesta-8, 14-diene-3, 23-diol, 9CI

C27H43ClO2 (434.2951)

C25H38O6

C25H38O6 (434.2668)

16-(4,9-dihydro-3H-beta-carbolin-1-yl)-17-nor-coryn-19-ene|3,4-Dihydro-usambarensin

C29H30N4 (434.247)

methyl-17-isovaleryloxy-grindeloate

C26H42O5 (434.3032)

seco-pseudopterosin J

C25H38O6 (434.2668)

7-oxo-13alpha-methoxy-8,11,13-abietatriene-18-succinic acid|abiesadine U

C25H38O6 (434.2668)

3,21-Di-Ac-(3alpha,5beta)-3,14,21-Trihydroxypregnan-20-one

C25H38O6 (434.2668)

bakkenolide-O

C25H38O6 (434.2668)

4-farnesyl-3,5,4-trihydroxybibenzyl

C29H38O3 (434.2821)

suvanine

C25H38O4S (434.2491)

3,21-Di-Ac-(3beta,5alpha,17alphaOH)-3,17,21-Trihydroxypregnan-20-one

C25H38O6 (434.2668)

petrosiacetylene C

C30H42O2 (434.3185)

methyl-3alpha-angeloyloxy-2alpha-hydroxycativate

C26H42O5 (434.3032)

17-Angeloyl-(ent-12alpha,16alphaOH)-12,16,17-Trihydroxy-19-kauranoic acid|ent-12alpha,16alpha-dihydroxy-17-angeloxykauran-19-oic acid

C25H38O6 (434.2668)

8alpha,15(S),23alpha-trihydroxy-23,6alpha-epoxy-labd-13(14),17-dien-16(S),19-olide

C25H38O6 (434.2668)

ligulamulienin B

C29H38O3 (434.2821)

petrosaspongiolide G

C25H38O6 (434.2668)

C17H34N6O7

C17H34N6O7 (434.2489)

Secopseudopterosin A

C25H38O6 (434.2668)

N,N-demethylisoalfileramine

C28H38N2O2 (434.2933)

(10R,6E)-7,11-dimethyl-3-methylene-6-dodecaene-1,2,10,11-tetraol 10-O-beta-D-glucopyranoside|trikamsesquiside A

C21H38O9 (434.2516)

2-hydroxy-3-[(1-oxododecyl)oxy]propyl-beta-D-glucopyranoside

C22H42O8 (434.288)

(7alpha)-7-[4-(2-hydroxy-1-methylethyl)benzyl]abieta-8,11,13-trien-12-ol|ferrugimenthenol

C30H42O2 (434.3185)

ent-19-(Z)-coumaroyloxylabda-8(17),13(16),14-triene

C29H38O3 (434.2821)

18-O-(E)-p-coumaroylbeyer-15-ene-18-ol|obtsurin B

C29H38O3 (434.2821)

Antibiotic SU4

C19H38N4O7 (434.274)

Gypensapogenin B

C30H42O2 (434.3185)

Gypensapogenin A

C30H42O2 (434.3185)

C21H38O9

C21H38O9 (434.2516)

Na, Nb-Didemethylisoalfileramine|Na,Nb-Di-de-Me-Isoalfileramine

C28H38N2O2 (434.2933)

bakkenolide-Q

C25H38O6 (434.2668)

Colupdol

C25H38O6 (434.2668)

abiesadine V|methyl 7-oxo-13beta-hydroxy-8,11,13-abietatriene-18-succinate

C25H38O6 (434.2668)

12beta,16beta,22-trihydroxy-24alpha-methylscalar-25beta,24alpha-olide

C26H42O5 (434.3032)

3alpha-acetoxy-7alpha-hydroxy-5beta-cholan-24-oic acid

C26H42O5 (434.3032)

Tri-Ac-(3beta,5alpha,6alpha,17alpha)-Androstane-3,6,17-triol

C25H38O6 (434.2668)

methyl-18-(2-methylbutyryloxy)-grindeloate|methyl-18-<2-methylbutyryloxy>-grindeloate

C26H42O5 (434.3032)

longipinane-7beta,8alpha,9alpha-triol-1-one 7-angelate-8-methylbutyrate

C25H38O6 (434.2668)

methyl-17-(2-methylbutyryloxy)-grindeloate|methyl-17-<2-methylbutyryloxy>-grindeloate

C26H42O5 (434.3032)

6alpha,8alpha,15(S)-trihydroxy-23-oxo-labd-13(14),17-dien-16(S),19-olide

C25H38O6 (434.2668)

9beta-acetoxy-11beta,12beta-epoxy-13alpha-hydroxy-3alpha-propionoxy-1beta,8beta-trinervit-15(17)-ene

C25H38O6 (434.2668)

methyl-18-isovaleryloxygrindeloate

C26H42O5 (434.3032)

2alpha-Angeloyloxy-3beta-(2-methylbutanoyloxy)isodrimeninol

C25H38O6 (434.2668)

norzyggomphic acid

C29H38O3 (434.2821)

(ent-15beta)-2,3-Dihydroxy-2-methylbutanoyl-15-Hydroxy-16-kauren-19-oic acid|2,3-Dihydroxy-2-methylbutanoyl-15-Hydroxy-16-kauren-19-oic acid

C25H38O6 (434.2668)

8-Angeloyl,9-(3-mehtylbutanoyl)-(3beta,8alpha,9beta,10b)-8,9,10-Trihydroxy-5-longipinanone

C25H38O6 (434.2668)

dicurcuphenol ether F

C30H42O2 (434.3185)

11-hydroxy-8,11,13-abietatriene 12-O-beta-D-xylopyranoside

C25H38O6 (434.2668)

phenylalanylisoleucylarginine

C21H34N6O4 (434.2641)

isoleucylphenylalanylarginine

C21H34N6O4 (434.2641)

Phe Arg Ile

C21H34N6O4 (434.2641)

Ile Arg Phe

C21H34N6O4 (434.2641)

Arg Ile Phe

C21H34N6O4 (434.2641)

13-oxo-7-[3,4,5-trihydroxy-6-(methoxymethyl)oxan-2-yl]oxytetradecanoic acid

C21H38O9 (434.2516)

[(2R)-2-[(E,2S,4R)-4,6-dimethyloct-6-en-2-yl]-6-oxo-2,3-dihydropyran-3-yl] (2E,4E,6S)-8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

C25H38O6 (434.2668)

19,20-dihydrousambarensine

C29H30N4 (434.247)

Bis[2-(2-butoxyethoxy)ethyl] adipate

C22H42O8 (434.288)

CONFIDENCE standard compound; INTERNAL_ID 1254; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9768; ORIGINAL_PRECURSOR_SCAN_NO 9763 CONFIDENCE standard compound; INTERNAL_ID 1254; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9764; ORIGINAL_PRECURSOR_SCAN_NO 9760 CONFIDENCE standard compound; INTERNAL_ID 1254; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9787; ORIGINAL_PRECURSOR_SCAN_NO 9784 CONFIDENCE standard compound; INTERNAL_ID 1254; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9800; ORIGINAL_PRECURSOR_SCAN_NO 9798 CONFIDENCE standard compound; INTERNAL_ID 1254; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9802; ORIGINAL_PRECURSOR_SCAN_NO 9800 CONFIDENCE standard compound; INTERNAL_ID 1254; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9812; ORIGINAL_PRECURSOR_SCAN_NO 9809

Ala Phe Val Val

C22H34N4O5 (434.2529)

Ala Val Phe Val

C22H34N4O5 (434.2529)

Ala Val Val Phe

C22H34N4O5 (434.2529)

Phe Ala Val Val

C22H34N4O5 (434.2529)

Phe Gly Ile Val

C22H34N4O5 (434.2529)

Phe Gly Leu Val

C22H34N4O5 (434.2529)

Phe Gly Val Ile

C22H34N4O5 (434.2529)

Phe Gly Val Leu

C22H34N4O5 (434.2529)

Phe Ile Gly Val

C22H34N4O5 (434.2529)

Phe Ile Val Gly

C22H34N4O5 (434.2529)

Phe Leu Gly Val

C22H34N4O5 (434.2529)

Phe Leu Val Gly

C22H34N4O5 (434.2529)

Phe Val Ala Val

C22H34N4O5 (434.2529)

Phe Val Gly Ile

C22H34N4O5 (434.2529)

Phe Val Gly Leu

C22H34N4O5 (434.2529)

Phe Val Ile Gly

C22H34N4O5 (434.2529)

Phe Val Leu Gly

C22H34N4O5 (434.2529)

Phe Val Val Ala

C22H34N4O5 (434.2529)

Gly Phe Ile Val

C22H34N4O5 (434.2529)

Gly Phe Leu Val

C22H34N4O5 (434.2529)

Gly Phe Val Ile

C22H34N4O5 (434.2529)

Gly Phe Val Leu

C22H34N4O5 (434.2529)

Gly Ile Phe Val

C22H34N4O5 (434.2529)

Gly Ile Val Phe

C22H34N4O5 (434.2529)

Gly Leu Phe Val

C22H34N4O5 (434.2529)

Gly Leu Val Phe

C22H34N4O5 (434.2529)

Gly Val Phe Ile

C22H34N4O5 (434.2529)

Gly Val Phe Leu

C22H34N4O5 (434.2529)

Gly Val Ile Phe

C22H34N4O5 (434.2529)

Gly Val Leu Phe

C22H34N4O5 (434.2529)

Ile Phe Gly Val

C22H34N4O5 (434.2529)

Ile Phe Val Gly

C22H34N4O5 (434.2529)

Ile Gly Phe Val

C22H34N4O5 (434.2529)

Ile Gly Val Phe

C22H34N4O5 (434.2529)

Ile Val Phe Gly

C22H34N4O5 (434.2529)

Ile Val Gly Phe

C22H34N4O5 (434.2529)

Phe Leu Arg

C21H34N6O4 (434.2641)

Leu Phe Gly Val

C22H34N4O5 (434.2529)

Leu Phe Val Gly

C22H34N4O5 (434.2529)

Leu Gly Phe Val

C22H34N4O5 (434.2529)

Leu Gly Val Phe

C22H34N4O5 (434.2529)

Leu Arg Phe

C21H34N6O4 (434.2641)

Arg Leu Phe

C21H34N6O4 (434.2641)

Leu Val Phe Gly

C22H34N4O5 (434.2529)

Leu Val Gly Phe

C22H34N4O5 (434.2529)

Phe Ile Arg

C21H34N6O4 (434.2641)

Ile Phe Arg

C21H34N6O4 (434.2641)

Arg Phe Leu

C21H34N6O4 (434.2641)

Leu Phe Arg

C21H34N6O4 (434.2641)

Phe Arg Leu

C21H34N6O4 (434.2641)

Arg Phe Ile

C21H34N6O4 (434.2641)

Val Ala Phe Val

C22H34N4O5 (434.2529)

Val Ala Val Phe

C22H34N4O5 (434.2529)

Val Phe Ala Val

C22H34N4O5 (434.2529)

Val Phe Gly Ile

C22H34N4O5 (434.2529)

Val Phe Gly Leu

C22H34N4O5 (434.2529)

Val Phe Ile Gly

C22H34N4O5 (434.2529)

Val Phe Leu Gly

C22H34N4O5 (434.2529)

Val Phe Val Ala

C22H34N4O5 (434.2529)

Val Gly Phe Ile

C22H34N4O5 (434.2529)

Val Gly Phe Leu

C22H34N4O5 (434.2529)

Val Gly Ile Phe

C22H34N4O5 (434.2529)

Val Gly Leu Phe

C22H34N4O5 (434.2529)

Val Ile Phe Gly

C22H34N4O5 (434.2529)

Val Ile Gly Phe

C22H34N4O5 (434.2529)

Val Leu Phe Gly

C22H34N4O5 (434.2529)

Val Leu Gly Phe

C22H34N4O5 (434.2529)

6-Hydroxysimvastatin

C25H38O6 (434.2668)

3-Hydroxysimvastatin

C25H38O6 (434.2668)

6-Hydroxymethylsimvastatin

C25H38O6 (434.2668)

Val Val Ala Phe

C22H34N4O5 (434.2529)

Val Val Phe Ala

C22H34N4O5 (434.2529)

1a,25-dihydroxy-3-deoxy-3-thiavitamin D3 3-oxide / 1a,25-dihydroxy-3-deoxy-3-thiacholecalciferol 3-oxide

C26H42O3S (434.2855)

(5Z,7E)-(1R,3R)-1,25-dihydroxy-9,10-seco-3-thia-5,7,10(19)-cholestatriene3-oxide

C26H42O3S (434.2855)

(5Z,7E)-(1R,3S)-1,25-dihydroxy-9,10-seco-3-thia-5,7,10(19)-cholestatrien 3-oxide

C26H42O3S (434.2855)

1α,25-dihydroxy-22-thiavitamin D3 / 1α,25-dihydroxy-22-thiacholecalciferol

C26H42O3S (434.2855)

1α,25-dihydroxy-22-thia-20-epivitamin D3 / 1α,25-dihydroxy-22-thia-20-epicholecalciferol

C26H42O3S (434.2855)

1α,25-dihydroxy-23-thiavitamin D3 / 1α,25-dihydroxy-23-thiacholecalciferol

C26H42O3S (434.2855)

(5Z,7E)-(1S,3R,24R)-22-oxa-9,10-seco-5,7,10(19)-cholestatriene-1,3,24,25-tetrol

C26H42O5 (434.3032)

(5Z,7E)-(1S,3R,24S)-22-oxa-9,10-seco-5,7,10(19)-cholestatriene-1,3,24,25-tetrol

C26H42O5 (434.3032)

(5Z,7E)-(1S,3R,25R)-22-oxa-9,10-seco-5,7,10(19)-cholestatriene-1,3,25,26-tetrol

C26H42O5 (434.3032)

(5Z,7E)-(1S,3R,25S)-22-oxa-9,10-seco-5,7,10(19)-cholestatriene-1,3,25,26-tetrol

C26H42O5 (434.3032)

(5Z,7E)-(1S,3R)-24-(dimethylphosphoryl)-9,10-seco-5,7,10(19)-cholatriene-1,3-diol

C26H43O3P (434.295)

(5Z,7E)-(1S,3R,24R)-25-fluoro-9,10-seco-5,7,10(19)-cholestatriene-1,3,24-triol

C27H43FO3 (434.3196)

(5Z,7E,10Z)-(1S,3R)-19-fluoro-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol

C27H43FO3 (434.3196)

(5Z,7E,10E)-(1S,3R)-19-fluoro-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol

C27H43FO3 (434.3196)

(5E,7E,10Z)-(1S,3R)-19-fluoro-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol

C27H43FO3 (434.3196)

(5E,7E,10E)-(1S,3R)-19-fluoro-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol

C27H43FO3 (434.3196)

24R-fluoro-1α,25-dihydroxyvitamin D3 / 24R-fluoro-1α,25-dihydroxycholecalciferol

C27H43FO3 (434.3196)

2β-fluoro-1α,25-dihydroxyvitamin D3

C27H43FO3 (434.3196)

1,24-Dihydroxy-25-fluorovitamin D3

C27H43FO3 (434.3196)

1alpha,25-dihydroxy-3-deoxy-3-thiavitamin D3 3-oxide / 1alpha,25-dihydroxy-3-deoxy-3-thiacholecalciferol 3-oxide

C26H42O3S (434.2855)

(5E,7E)-(1R,3S)-1,25-dihydroxy-9,10-seco-3-thia-5,7,10(19)-cholestatriene 3-oxide

C26H42O3S (434.2855)

3alpha,7alpha,12alpha-Trihydroxy-5beta-23E-cholestan-26-oic acid

C26H42O5 (434.3032)

CJ 14258

C25H38O6 (434.2668)

b-Citraurinol

C30H42O2 (434.3185)

Tween 60

C22H42O8 (434.288)

butyl oleate sulfate

C22H42O6S (434.2702)

Apadoline

C25H38O6 (434.2668)

1alpha,25-dihydroxy-3-deoxy-3-thiavitamin D3 3-oxide

C26H42O3S (434.2855)

(5E)-(3S)-1alpha,25-dihydroxy-3-deoxy-3-thiavitamin D3 3-oxide

C26H42O3S (434.2855)

(5Z)-1alpha,25-dihydroxy-3-deoxy-3-thiavitamin D3 3-oxide

C26H42O3S (434.2855)

(5Z)-(3S)-1alpha,25-dihydroxy-3-deoxy-3-thiavitamin D3 3-oxide

C26H42O3S (434.2855)

1alpha,25-dihydroxy-22-thiavitamin D3

C26H42O3S (434.2855)

1alpha,25-dihydroxy-22-thia-20-epivitamin D3

C26H42O3S (434.2855)

1alpha,25-dihydroxy-23-thiavitamin D3

C26H42O3S (434.2855)

(24R)-1alpha,24,25-trihydroxy-22-oxavitamin D3 / (24R)-1alpha,24,25-trihydroxy-22-oxacholecalciferol

C26H42O5 (434.3032)

(24S)-1alpha,24,25-trihydroxy-22-oxavitamin D3 / (24S)-1alpha,24,25-trihydroxy-22-oxacholecalciferol

C26H42O5 (434.3032)

(25R)-1alpha,25,26-trihydroxy-22-oxavitamin D3 / (25R)-1alpha,25,26-trihydroxy-22-oxacholecalciferol

C26H42O5 (434.3032)

(25S)-1alpha,25,26-trihydroxy-22-oxavitamin D3 / (25S)-1alpha,25,26-trihydroxy-22-oxacholecalciferol

C26H42O5 (434.3032)

1alpha-hydroxy-24-(dimethylphosphoryl)-25,26,27-trinorvitamin D3

C26H43O3P (434.295)

(24R)-25-fluoro-1alpha,24-dihydroxyvitamin D3

C27H43O3F (434.3196)

(10Z)-19-fluoro-1alpha,25-dihydroxyvitamin D3 / (10Z)-19-fluoro-1alpha,25-dihydroxycholecalciferol

C27H43FO3 (434.3196)

(10E)-19-fluoro-1alpha,25-dihydroxyvitamin D3 / (10E)-19-fluoro-1alpha,25-dihydroxycholecalciferol

C27H43FO3 (434.3196)

24R-fluoro-1alpha,25-dihydroxyvitamin D3

C27H43O3F (434.3196)

2beta-fluoro-1alpha,25-dihydroxyvitamin D3

C27H43O3F (434.3196)

ST 26:2;O5

C26H42O5 (434.3032)

(+)-Cuminone A

C26H42O5 (434.3032)

(-)-Cuminone A

C26H42O5 (434.3032)

1,5-bis(p-hexyloxyphenyl)-1,4-pentadien-3-one

C29H38O3 (434.2821)

4-(TERT-BUTYLDIMETHYLSILANYLOXY)-6-[2-(8-HYDROXY-2,6-DIMETHYL-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL)ETHYL]TETRAHYDROPYRAN-2-ONE

C25H42O4Si (434.2852)

Trt-Thr-OH.DEA

C27H34N2O3 (434.2569)

Polysulfides, di-tert-dodecyl

C24H50S3 (434.3074)

10-CARBOXYDECYL DISULFIDE

C22H42O4S2 (434.2524)

2-methyl-2-(2-methylundecan-2-yltrisulfanyl)undecane

C24H50S3 (434.3074)

methyl 2-[[(2E)-2-benzylideneoctylidene]amino]benzoate

C27H34N2O3 (434.2569)

glycerol propoxylate triglycidyl ether

C21H38O9 (434.2516)

ammonium sulfobetaine-3

C22H46N2O4S (434.3178)

Aliskiren inter-7

C26H42O5 (434.3032)

(S)-1-CYCLOHEXYL-4-(4-(2-METHOXYPHENYL)PIPERAZIN-1-YL)-2-METHYL-2-PHENYLBUTAN-1-ONE

C28H38N2O2 (434.2933)

5-octadecoxybenzene-1,3-dicarboxylic acid

C26H42O5 (434.3032)

Butoprozine

C28H38N2O2 (434.2933)

2-(4-piperazin-1-ylanilino)-N-(4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl)pyrimidine-4-carboxamide

C25H34N6O (434.2794)

1 4-BIS(DIMETHYL(2-(5-NORBORNEN-2-YL)ET&

C28H42Si2 (434.2825)

sodium hydrogen N-(1-oxooctadecyl)-L-glutamate

C23H41NNaO5 (434.2882)

2-FLUORO-5-(AMINOMETHYL)PYRIDINE

C24H38N2O5 (434.2781)

(9,9-dioctylfluoren-2-yl)boronic acid

C29H43BO2 (434.3356)

2-[2-(2,3-dihydro-5-methoxy-2,3,3-trimethyl-1H-indol-1-yl)vinyl]-1,3,3-trimethyl-3H-indolium acetate

C27H34N2O3 (434.2569)

magnesium octadecylbenzenesulphonate

C24H42MgO3S (434.2705)

N-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine,formaldehyde,2-[(2-methylphenoxy)methyl]oxirane,phenol

C23H38N4O4 (434.2893)

Dimethyl ocatadecyl aminoium hydroxy propylsulfonate

C23H48NO4S (434.3304)

3,3,5,5-Tetra-tert-butyl-4,4-stilbenequinone

C30H42O2 (434.3185)

Oxogestone phenpropionate

C29H38O3 (434.2821)

C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone

(1R,3S,5E)-5-[(2E)-2-[(3aS,7aR)-1-[1-(2-hydroxy-2-methylpropyl)sulfanylpropan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol

C26H42O3S (434.2855)

D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols

(1R)-4-[(1E,3E,5E,7Z,9E,11Z,13E,15E)-17-Hydroxy-3,7,12,16-tetramethylheptadeca-1,3,5,7,9,11,13,15-octaen-1-YL]-3,5,5-trimethylcyclohex-3-EN-1-OL

C30H42O2 (434.3185)

Ribociclib

C23H30N8O (434.2542)

L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EF - Cyclin-dependent kinase (cdk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent

(5Z)-1alpha,25-dihydroxy-3-deoxy-3-thiavitamin D3 3-oxide/(5Z)-1alpha,25-dihydroxy-3-deoxy-3-thiacholecalciferol 3-oxide

C26H42O3S (434.2855)

(24R)-1alpha,24,25-trihydroxy-22-oxavitamin D3/(24R)-1alpha,24,25-trihydroxy-22-oxacholecalciferol

C26H42O5 (434.3032)

(2R)-2-acetamido-3-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]sulfanylpropanoate

C25H40NO3S- (434.2729)

4,4-Diaponeurosporen-1,1-diol

C30H42O2 (434.3185)

13-(Hydroxymethyl)-2,5-dimethyl-8-propan-2-yl-15,20,22-trioxapentacyclo[12.8.0.02,10.05,9.016,21]docosa-8,12-diene-17,18-diol

C25H38O6 (434.2668)

MG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/0:0)

C25H38O6 (434.2668)

MG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/0:0)

C25H38O6 (434.2668)

MG(0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

C25H38O6 (434.2668)

MG(0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C25H38O6 (434.2668)

(5Z)-5-[(2E)-2-[1-(5-fluoro-6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol

C27H43FO3 (434.3196)

DG(2:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C25H38O6 (434.2668)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/2:0/0:0)

C25H38O6 (434.2668)

DG(2:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C25H38O6 (434.2668)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/2:0)

C25H38O6 (434.2668)

DG(2:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C25H38O6 (434.2668)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/2:0/0:0)

C25H38O6 (434.2668)

DG(2:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C25H38O6 (434.2668)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/2:0)

C25H38O6 (434.2668)

DG(2:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C25H38O6 (434.2668)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/2:0/0:0)

C25H38O6 (434.2668)

DG(2:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C25H38O6 (434.2668)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/2:0)

C25H38O6 (434.2668)

DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C25H38O6 (434.2668)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/2:0/0:0)

C25H38O6 (434.2668)

DG(2:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C25H38O6 (434.2668)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/2:0)

C25H38O6 (434.2668)

DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C25H38O6 (434.2668)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/2:0/0:0)

C25H38O6 (434.2668)

DG(2:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C25H38O6 (434.2668)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/2:0)

C25H38O6 (434.2668)

DG(2:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C25H38O6 (434.2668)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/2:0/0:0)

C25H38O6 (434.2668)

DG(2:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C25H38O6 (434.2668)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/2:0)

C25H38O6 (434.2668)

[3,9-Dicarboxy-2,10-dihydroxy-5-methyl-4,8-dioxo-11-(trimethylazaniumyl)undecyl]-trimethylazanium

C20H38N2O8+2 (434.2628)

Erinacine C

C25H38O6 (434.2668)

beta-Citraurol

C30H42O2 (434.3185)

Philanthotoxin-74

C24H42N4O3 (434.3257)

Phe-Leu-Arg

C21H34N6O4 (434.2641)

Leu-Arg-Phe

C21H34N6O4 (434.2641)

Phe-Arg-Leu

C21H34N6O4 (434.2641)

Phe-Ile-Arg

C21H34N6O4 (434.2641)

1-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

C23H38N4O4 (434.2893)

(8R,9S,10R)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C26H34N4O2 (434.2682)

(8R,9R,10R)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C26H34N4O2 (434.2682)

cyclohexyl-[(2S,3R)-2-(hydroxymethyl)-1-[(3-methoxyphenyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone

C27H34N2O3 (434.2569)

cyclohexyl-[(2R,3R)-2-(hydroxymethyl)-1-[(3-methoxyphenyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone

C27H34N2O3 (434.2569)

1-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

C23H38N4O4 (434.2893)

1-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

C23H38N4O4 (434.2893)

1-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

C23H38N4O4 (434.2893)

1-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

C23H38N4O4 (434.2893)

1-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

C23H38N4O4 (434.2893)

1-[[(2R,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

C23H38N4O4 (434.2893)

1-[[(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea

C23H38N4O4 (434.2893)

1-[(4R,7R,8S)-5-ethyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea

C23H38N4O4 (434.2893)

(8S,9S,10S)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C26H34N4O2 (434.2682)

(8R,9S,10S)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C26H34N4O2 (434.2682)

(8R,9R,10S)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C26H34N4O2 (434.2682)

(8S,9R,10R)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C26H34N4O2 (434.2682)

(8S,9R,10S)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C26H34N4O2 (434.2682)

(8S,9S,10R)-N-cyclopentyl-10-(hydroxymethyl)-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C26H34N4O2 (434.2682)

cyclohexyl-[(2S,3S)-2-(hydroxymethyl)-1-[(3-methoxyphenyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone

C27H34N2O3 (434.2569)

cyclohexyl-[(2R,3S)-2-(hydroxymethyl)-1-[(3-methoxyphenyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone

C27H34N2O3 (434.2569)

Ile-Phe-Arg

C21H34N6O4 (434.2641)

Arg-Ile-Phe

C21H34N6O4 (434.2641)

Arg-Phe-Ile

C21H34N6O4 (434.2641)

Phe-Arg-Ile

C21H34N6O4 (434.2641)

Arg-Leu-Phe

C21H34N6O4 (434.2641)

Arg-Phe-Leu

C21H34N6O4 (434.2641)

Ile-Arg-Phe

C21H34N6O4 (434.2641)

Leu-Phe-Arg

C21H34N6O4 (434.2641)

Buclizine(2+)

C28H35ClN2+2 (434.2489)

16-(beta-D-Glucopyranosyloxy)hexadecanoic acid

C22H42O8 (434.288)

[(4E,8E)-2-acetamido-3-hydroxytrideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C20H39N2O6P (434.2546)

[3-carboxy-2-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxypropyl]-trimethylazanium

C26H44NO4+ (434.327)

[(4E,8E)-3-hydroxy-2-(propanoylamino)dodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C20H39N2O6P (434.2546)

13-Oxo-7-[3,4,5-trihydroxy-6-(methoxymethyl)oxan-2-yl]oxytetradecanoic acid

C21H38O9 (434.2516)

(1-hydroxy-3-propanoyloxypropan-2-yl) (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C26H42O5 (434.3032)

(1-heptanoyloxy-3-hydroxypropan-2-yl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C26H42O5 (434.3032)

(1-hydroxy-3-pentanoyloxypropan-2-yl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C26H42O5 (434.3032)

2-[Carboxy-(3-dodecanoyloxy-2-hydroxypropoxy)methoxy]ethyl-trimethylazanium

C22H44NO7+ (434.3118)

(2R)-2-[(2R,3R,4S)-3,4-bis(2-hydroxyethoxy)oxolan-2-yl]-2-hydroxyethyl dodecanoate

C22H42O8 (434.288)

(12S,15S)-15-O-Demethyl-10,29-dideoxy-11,12-dihydro-striatin C

C25H38O6 (434.2668)

TG(22:4)

C25H38O6 (434.2668)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

NA-Gln 20:3(8Z,11Z,14Z)

C25H42N2O4 (434.3144)

MGMG 12:1

C21H38O9 (434.2516)

ST 19:2;O;Hex

C25H38O6 (434.2668)

ST 25:3;O;S

C25H38O4S (434.2491)

ST 25:3;O6

C25H38O6 (434.2668)

ST 29:7;O3

C29H38O3 (434.2821)

INCB38579

C25H34N6O (434.2794)

INCB38579 is an orally active, highly brain penetrable, and selective histamine H4 receptor (HH4R) antagonist (hH4R IC50=4.8 nM, mH4R IC50=42 nM, rH4R IC50=32 nM). INCB38579 shows anti-inflammatory pain and anti-pruritic activities[1].

5',8-diisopropyl-2,3',5,8'-tetramethyl-5h,5'h,6h,6'h,7h,7'h,8h,8'h-[1,2'-binaphthalene]-1',4-diol

C30H42O2 (434.3185)

(2r,3r,4ar,6ar,8s,10r,10ar,10bs)-3-ethenyl-2,10-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-8-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)

2-(hydroxymethyl)-6-[(3,10,11-trihydroxy-3,7,11-trimethyldodeca-1,6-dien-5-yl)oxy]oxane-3,4,5-triol

C21H38O9 (434.2516)

5-(propan-2-ylidene)-3-[(1r,3s,6r,7s,10r,11r,16s)-10,11,15,15-tetramethyl-19-oxapentacyclo[14.2.1.0²,¹⁴.0³,¹¹.0⁶,¹⁰]nonadec-2(14)-en-7-yl]cyclopent-2-en-1-one

C30H42O2 (434.3185)

(2r,3r)-2-[(2s,4r,6e)-4,6-dimethyloct-6-en-2-yl]-6-oxo-2,3-dihydropyran-3-yl (2e,4e,6s)-8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

C25H38O6 (434.2668)

(2r,3r,4s,5s,6r)-2-{[(1r,2r,4ar,5r,8r,8as)-5,8-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O9 (434.2516)

(2r,3r,4s,5s,6r)-2-{[(1r,2r,4as,5s,8s)-5,8-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O9 (434.2516)

methyl (3s)-3-ethoxy-3-[(1r,2s)-2-hydroxy-4-oxo-1-[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]cyclopentyl]propanoate

C26H42O5 (434.3032)

{5-ethenyl-1,5,7,12,12-pentamethyl-11-[(2-methylbut-2-enoyl)oxy]-6,8-dioxatricyclo[7.4.0.0²,⁷]tridecan-13-yl}acetic acid

C25H38O6 (434.2668)

(3r,4s,6e,8e,10s)-2,10-dihydroxy-2,6,10-trimethyl-3-{[(2e)-2-methylbut-2-enoyl]oxy}dodeca-6,8,11-trien-4-yl (2e)-2-methylbut-2-enoate

C25H38O6 (434.2668)

[(1s,4r,5r,9r,10r,13r)-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-5-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C29H38O3 (434.2821)

[(1s,4r,5r,9r,10r,13r)-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-5-yl]methyl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C29H38O3 (434.2821)

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(3s,5s,6e,10r)-3,10,11-trihydroxy-3,7,11-trimethyldodeca-1,6-dien-5-yl]oxy}oxane-3,4,5-triol

C21H38O9 (434.2516)

(1r,5r,10r,16r,18r)-13-(hydroxymethyl)-8-isopropyl-2,5-dimethyl-15,20,22-trioxapentacyclo[12.8.0.0²,¹⁰.0⁵,⁹.0¹⁶,²¹]docosa-8,12-diene-17,18-diol

C25H38O6 (434.2668)

3-ethyl-2-{9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C29H30N4 (434.247)

2',6-dimethyl-3,5'-bis(6-methylhept-5-en-2-yl)-[1,1'-biphenyl]-2,4'-diol

C30H42O2 (434.3185)

7,7a-dimethyl-4-[(3-methylbutanoyl)oxy]-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

C25H38O6 (434.2668)

(2r,3r,4s,5s,6r)-2-{[(1r,2r,4as,5s,8s,8as)-5,8-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O9 (434.2516)

5'-(2-methoxy-2-oxoethyl)-5,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-2-ylmethyl 3-methylbutanoate

C26H42O5 (434.3032)

(2z,6z,10z)-12-(acetyloxy)-6-[(acetyloxy)methyl]-10-methyl-2-(4-methyl-3-methylidenepentyl)dodeca-2,6,10-trienoic acid

C25H38O6 (434.2668)

(1r,3s,4ar,6ar,8s,10r,10ar,10br)-3-ethenyl-1,10-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-8-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)

2-hydroxy-9-(hydroxymethyl)-5,9,13-trimethyl-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-22-one

C25H38O6 (434.2668)

(2z)-5-[(1r,2s,3r,4r,4ar,8ar)-3-(acetyloxy)-1,2,4a,5-tetramethyl-4-(2-methylpropoxy)-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpent-2-enoic acid

C26H42O5 (434.3032)

7,8-dihydroxy-3,4,8,8a-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-1h-naphthalen-1-yl 2-methylbut-2-enoate

C25H38O6 (434.2668)

2-(hydroxymethyl)-6-[(2,11,12-trihydroxy-2,6-dimethyl-10-methylidenedodec-6-en-3-yl)oxy]oxane-3,4,5-triol

C21H38O9 (434.2516)

3,4-diethyl-5-(2-ethyl-4-phenylbuta-1,3-dien-1-yl)-1,5,7-trimethyl-2-oxo-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C29H38O3 (434.2821)

(1s,2r,5r,10r,13s,14s,16s,17r,20s,21r,22r)-8-isopropyl-2,5-dimethyl-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricos-8-ene-14,17,21-triol

C25H38O6 (434.2668)

(1s,4as,5's,8as)-5'-(2-methoxy-2-oxoethyl)-5,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-2-ylmethyl 3-methylbutanoate

C26H42O5 (434.3032)

5'-(2-methoxy-2-oxoethyl)-2,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5-ylmethyl 3-methylbutanoate

C26H42O5 (434.3032)

(1r,5ar,7r,8r,9as,9br)-1-hydroxy-6,6,9a-trimethyl-7-{[(2r)-2-methylbutanoyl]oxy}-1h,3h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-8-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)

6,6'-dimethyl-3,3'-bis[(2s)-6-methylhept-5-en-2-yl]-[1,1'-biphenyl]-2,2'-diol

C30H42O2 (434.3185)

3-ethenyl-1,10-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-8-yl 2-methylbut-2-enoate

C25H38O6 (434.2668)

2-(4,6-dimethyloct-6-en-2-yl)-6-oxo-2,3-dihydropyran-3-yl 8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

C25H38O6 (434.2668)

(2s,3s,4r,5r)-2-{[(5r,8s)-2-hydroxy-3,8-dimethyl-5-[(2s)-6-methylhept-5-en-2-yl]-5,6,7,8-tetrahydronaphthalen-1-yl]oxy}oxane-3,4,5-triol

C25H38O6 (434.2668)

{5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-5-yl}methyl 3-(4-hydroxyphenyl)prop-2-enoate

C29H38O3 (434.2821)

2-[(1as,2r,2ar,5's,6ar,7s,7as)-7-hydroxy-1a,2a,5',6,6-pentamethyl-3-oxo-tetrahydro-4h-spiro[naphtho[2,3-b]oxirene-2,2'-oxolan]-5'-yl]ethyl 3-methylbut-2-enoate

C25H38O6 (434.2668)

(1e)-2-[(1s,2s,7s)-2-(4-hydroxy-4-methylpentyl)-5-(hydroxymethyl)-2-methyl-6-oxo-7-(2-oxopropyl)cyclohept-4-en-1-yl]ethenyl 3-methylbut-2-enoate

C25H38O6 (434.2668)

3-{[(2s,4as,5r,8as)-5-[(3e)-5-(acetyloxy)-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl]oxy}-3-oxopropanoic acid

C25H38O6 (434.2668)

(1r,3r,4r,4as,7s,8s,8as)-7,8-dihydroxy-3,4,8,8a-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-1h-naphthalen-1-yl (2e)-2-methylbut-2-enoate

C25H38O6 (434.2668)

(4r)-4-[(9as,11ar)-7,7-dimethoxy-9a,11a-dimethyl-4-oxo-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]pentanoic acid

C26H42O5 (434.3032)

5-[2,2-dimethyl-3-(3-oxobutyl)cyclopropyl]-3',3',6,7'-tetramethylspiro[bicyclo[2.2.1]heptane-2,11'-tetracyclo[5.4.0.0¹,⁸.0²,⁴]undecan]-5-en-10'-one

C30H42O2 (434.3185)

5-methyl-4-{5-methyl-2-[(2s)-6-methylhept-5-en-2-yl]phenoxy}-2-[(2s)-6-methylhept-5-en-2-yl]phenol

C30H42O2 (434.3185)

1-hydroxy-6,6,9a-trimethyl-7-[(2-methylbutanoyl)oxy]-1h,3h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-8-yl 2-methylbut-2-enoate

C25H38O6 (434.2668)

3-{[(2s,4ar,5r,8as)-5-[(3e)-5-(acetyloxy)-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl]oxy}-3-oxopropanoic acid

C25H38O6 (434.2668)

6,15-dihydroxy-4-(2-methylpropyl)-13-(sec-butyl)-19-oxa-2,5,11,14-tetraazatetracyclo[8.8.1.0²,¹⁶.0⁷,¹¹]nonadeca-5,14-diene-3,12-dione

C22H34N4O5 (434.2529)

(2r,3e,12bs)-3-ethylidene-2-{3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C29H30N4 (434.247)

[(3s,6s)-6-[(2s,5r)-5-[(9z,11z)-hexadeca-9,11,15-trien-1-yl]oxolan-2-yl]-1,2-dioxan-3-yl]acetic acid

C26H42O5 (434.3032)

2-[(4-hydroxy-2-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-3-yl)oxy]oxane-3,4,5-triol

C25H38O6 (434.2668)

8-isopropyl-2,5-dimethyl-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricos-8-ene-16,17,21-triol

C25H38O6 (434.2668)

(1's,2's,3r,3as,5's,7'r,8as,9as,10'r)-2',5,6',6',8a,9'-hexamethyl-4,6,7,8,9,9a-hexahydro-3ah-spiro[naphtho[2,3-b]furan-3,12'-tetracyclo[8.2.1.0¹,⁸.0⁵,⁷]tridecan]-8'-en-2-one

C30H42O2 (434.3185)

methyl 3-ethoxy-3-[2-hydroxy-4-oxo-1-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)cyclopentyl]propanoate

C26H42O5 (434.3032)

3-hydroxy-4,6b,8a,11,11,12b,14a-heptamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione

C29H38O3 (434.2821)

2,10-dihydroxy-2,6,10-trimethyl-3-[(2-methylbut-2-enoyl)oxy]dodeca-6,8,11-trien-4-yl 2-methylbut-2-enoate

C25H38O6 (434.2668)

3-ethenyl-1,8-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-10-yl 2-methylbut-2-enoate

C25H38O6 (434.2668)

4-[(3r,4ar,4bs,6as,7s,10ar,10bs,12as)-1-hydroxy-7-(hydroxymethyl)-4b,7,10a-trimethyl-tetradecahydrophenanthro[2,1-c]pyran-3-yl]-5-hydroxy-5h-furan-2-one

C25H38O6 (434.2668)

1-[8,8a-dimethyl-3-({3,4,5-trimethyl-5h,6h,7h,8h-naphtho[2,3-b]furan-2-yl}oxy)-4,4a,5,6,7,8-hexahydro-1h-naphthalen-2-yl]ethanone

C29H38O3 (434.2821)

7,7a-dimethyl-4-[(2-methylbutanoyl)oxy]-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

C25H38O6 (434.2668)

methyl({2-[(1r,2s,11r,13s)-3,3,13-trimethyl-18-[2-(methylamino)ethyl]-4,14-dioxapentacyclo[11.7.1.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]henicosa-5,7,9,15,17,19-hexaen-8-yl]ethyl})amine

C28H38N2O2 (434.2933)

(6bs,8as,12ar,12bs,14ar)-3-hydroxy-4,6b,8a,11,11,12b,14a-heptamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione

C29H38O3 (434.2821)

(1s,4as,5'r,8as)-5'-(2-methoxy-2-oxoethyl)-5,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-2-ylmethyl (2r)-2-methylbutanoate

C26H42O5 (434.3032)

[(1r,4ar,5s,6s,8ar)-6-[(2-hydroxy-3-methylbutanoyl)oxy]-5,8a-dimethyl-2-methylidene-5-(4-methylpent-3-en-1-yl)-hexahydro-1h-naphthalen-1-yl]acetic acid

C26H42O5 (434.3032)

(1r,4as,5r,5'r,8as)-5'-(2-methoxy-2-oxoethyl)-2,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5-ylmethyl (2r)-2-methylbutanoate

C26H42O5 (434.3032)

(2r,3r,4s,5s,6r)-2-{[(1r,2r,4as,5s,8s,8ar)-5,8-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O9 (434.2516)

(1s,4as,5'r,8as)-5'-(2-methoxy-2-oxoethyl)-5,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-2-ylmethyl 3-methylbutanoate

C26H42O5 (434.3032)

2-{2-hydroxy-6,10-dimethyl-4-[(2-methylbut-2-enoyl)oxy]-11-oxabicyclo[8.1.0]undec-6-en-3-yl}propyl 2-methylbut-2-enoate

C25H38O6 (434.2668)

(5s,5's,8s,8's)-5,5'-diisopropyl-3,3',8,8'-tetramethyl-5h,5'h,6h,6'h,7h,7'h,8h,8'h-[1,1'-binaphthalene]-2,2'-diol

C30H42O2 (434.3185)

(2s)-2-[(2s)-n,3-dimethyl-2-(methylamino)butanamido]-n-[2-(1h-indol-3-yl)ethyl]-3-phenylpropanimidic acid

C26H34N4O2 (434.2682)

5-(propan-2-ylidene)-2-[(1r,3s,6r,7s,10r,11r,16s)-10,11,15,15-tetramethyl-19-oxapentacyclo[14.2.1.0²,¹⁴.0³,¹¹.0⁶,¹⁰]nonadec-2(14)-en-7-yl]cyclopent-2-en-1-one

C30H42O2 (434.3185)

methyl (4as,4br,7r,7ar,10ar,11r,12as)-11-(butanoyloxy)-1,1,4a-trimethyl-8-oxo-dodecahydrophenanthro[1,10a-c]furan-7-carboxylate

C25H38O6 (434.2668)

3-(2,4a,4b,8,8a,10a-hexamethyl-1,2,3,4,5,6,9,10-octahydrophenanthrene-1-carbonyloxy)-2-hydroxypropyl acetate

C26H42O5 (434.3032)

[(3as,3bs,5as,9as,9br,10s,11as)-10-(acetyloxy)-6,6,9a,11a-tetramethyl-2-oxo-decahydro-3h-phenanthro[2,1-b]furan-3b-yl]methyl acetate

C25H38O6 (434.2668)

(1s,2r,4r,5s,8r,9s,13r,14s,17s,18s,20s)-2-hydroxy-9-(hydroxymethyl)-5,9,13-trimethyl-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-22-one

C25H38O6 (434.2668)

(1s,2r,5r,10r,13s,16s,17r,20s,21s,22r)-8-isopropyl-2,5-dimethyl-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricos-8-ene-16,17,21-triol

C25H38O6 (434.2668)

1-[(1s,2r,4as,8ar)-1-(4-methoxy-3-methylidene-4-oxobutyl)-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl 4-methyl butanedioate

C25H38O6 (434.2668)

6-hydroxy-3,3,7,9-tetramethyl-5-[(2-methylbutanoyl)oxy]-11-oxotricyclo[5.4.0.0²,⁸]undecan-4-yl 2-methylbut-2-enoate

C25H38O6 (434.2668)

methyl (1s,4ar,5s,8ar)-5-[(4s)-4,5-bis(acetyloxy)-3-methylidenepentyl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate

C25H38O6 (434.2668)

(2r,3r,3ar,4s,7s,7ar)-7,7a-dimethyl-4-[(3-methylbutanoyl)oxy]-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

C25H38O6 (434.2668)

2-{[5,8-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O9 (434.2516)

2,2'-dimethyl-5,5'-bis[(2s)-6-methylhept-5-en-2-yl]-[1,1'-biphenyl]-4,4'-diol

C30H42O2 (434.3185)

12-(acetyloxy)-6-[(acetyloxy)methyl]-10-methyl-2-(4-methyl-3-methylidenepentyl)dodeca-2,6,10-trienoic acid

C25H38O6 (434.2668)

(2s)-2-hydroxy-21-methyl-3-oxodocosane-1-sulfonic acid

C23H46O5S (434.3066)

(2r,3r,3ar,4s,7s,7ar)-7,7a-dimethyl-4-[(2-methylbutanoyl)oxy]-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

C25H38O6 (434.2668)

2',6-dimethyl-3,5'-bis[(2s)-6-methylhept-5-en-2-yl]-[1,1'-biphenyl]-2,4'-diol

C30H42O2 (434.3185)

(2r,3r,4s,5s,6r)-2-{[(1r,2r,4as,5s,8r)-5,8-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O9 (434.2516)

4-[2-(methylamino)ethyl]-2-{6,6,9-trimethyl-2-[2-(methylamino)ethyl]-6ah,7h,10h,10ah-benzo[c]isochromen-7-yl}phenol

C28H38N2O2 (434.2933)

2-[(6ar,7s,10ar)-6,6,9-trimethyl-2-[2-(methylamino)ethyl]-6ah,7h,10h,10ah-benzo[c]isochromen-7-yl]-4-[2-(methylamino)ethyl]phenol

C28H38N2O2 (434.2933)

(2s,3r,4s,5r)-2-{[(4bs,8as)-4-hydroxy-2-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-3-yl]oxy}oxane-3,4,5-triol

C25H38O6 (434.2668)

[(1s,2s,5s,7s,9s,11s,13r)-5-ethenyl-1,5,7,12,12-pentamethyl-11-{[(2z)-2-methylbut-2-enoyl]oxy}-6,8-dioxatricyclo[7.4.0.0²,⁷]tridecan-13-yl]acetic acid

C25H38O6 (434.2668)

4-{7,7-dimethoxy-9a,11a-dimethyl-4-oxo-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl}pentanoic acid

C26H42O5 (434.3032)

3-({5-[5-(acetyloxy)-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl}oxy)-3-oxopropanoic acid

C25H38O6 (434.2668)

(1r,2r,5r,10r,14r,16r,17s,18r,21s)-13-(hydroxymethyl)-8-isopropyl-2,5-dimethyl-15,20,22-trioxapentacyclo[12.8.0.0²,¹⁰.0⁵,⁹.0¹⁶,²¹]docosa-8,12-diene-17,18-diol

C25H38O6 (434.2668)

(1s,2s,3s,5s,8s,10s,14s)-2-(acetyloxy)-5,10-dihydroxy-8,12,15,15-tetramethyl-4-methylidenetricyclo[9.3.1.0³,⁸]pentadec-11-en-14-yl propanoate

C25H38O6 (434.2668)

(2s,3s,4r,5r)-2-{[(5r,8s)-1-hydroxy-3,8-dimethyl-5-[(2s)-6-methylhept-5-en-2-yl]-5,6,7,8-tetrahydronaphthalen-2-yl]oxy}oxane-3,4,5-triol

C25H38O6 (434.2668)

2-{7-hydroxy-1a,2a,5',6,6-pentamethyl-3-oxo-tetrahydro-4h-spiro[naphtho[2,3-b]oxirene-2,2'-oxolan]-5'-yl}ethyl 3-methylbut-2-enoate

C25H38O6 (434.2668)

(1r,3s,4ar,6ar,8s,10r,10ar,10br)-3-ethenyl-1,8-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-10-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)

3-ethenyl-2,10-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-8-yl 2-methylbut-2-enoate

C25H38O6 (434.2668)

methyl 5-[4,5-bis(acetyloxy)-3-methylidenepentyl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate

C25H38O6 (434.2668)

(1s,2r,4r,5s,9s,13r,17s,18s,20s)-2-hydroxy-9-(hydroxymethyl)-5,9,13-trimethyl-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-22-one

C25H38O6 (434.2668)

(1s,4s,5r,9s,10r,12r,13s,14s)-12,14-dihydroxy-5,9-dimethyl-14-({[(2z)-2-methylbut-2-enoyl]oxy}methyl)tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

C25H38O6 (434.2668)

(1r)-1-[(1r,2r,5r,7r,8r,10s,11r,14s,15r)-8-(acetyloxy)-10,11-dihydroxy-2,15-dimethylpentacyclo[8.7.0.0²,⁷.0⁵,⁷.0¹¹,¹⁵]heptadecan-14-yl]ethyl acetate

C25H38O6 (434.2668)

3-ethylidene-2-{3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C29H30N4 (434.247)

(2r,3r,4s,5s,6r)-2-{[(1r,2r,4as,5s,8r,8ar)-5,8-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O9 (434.2516)

methyl(2-{3,3,13-trimethyl-8-[2-(methylamino)ethyl]-4,14-dioxapentacyclo[11.7.1.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]henicosa-5,7,9,15,17,19-hexaen-18-yl}ethyl)amine

C28H38N2O2 (434.2933)

(1s,4s,7s,10s,13s,16s)-4-[(2s)-butan-2-yl]-6,15-dihydroxy-13-(2-methylpropyl)-19-oxa-2,5,11,14-tetraazatetracyclo[8.8.1.0²,¹⁶.0⁷,¹¹]nonadeca-5,14-diene-3,12-dione

C22H34N4O5 (434.2529)

5-[3-(acetyloxy)-1,2,4a,5-tetramethyl-4-(2-methylpropoxy)-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpent-2-enoic acid

C26H42O5 (434.3032)

6-[2,2-dimethyl-3-(3-oxobutyl)cyclopropyl]-3',3',5,7'-tetramethylspiro[bicyclo[2.2.1]heptane-2,11'-tetracyclo[5.4.0.0¹,⁸.0²,⁴]undecan]-5-en-10'-one

C30H42O2 (434.3185)

2,2'-dimethyl-5,5'-bis(6-methylhept-5-en-2-yl)-[1,1'-biphenyl]-4,4'-diol

C30H42O2 (434.3185)

(3r,4s,6e,8e,10s)-2,10-dihydroxy-2,6,10-trimethyl-3-{[(2z)-2-methylbut-2-enoyl]oxy}dodeca-6,8,11-trien-4-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)

5'-(2-methoxy-2-oxoethyl)-5,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-2-ylmethyl 2-methylbutanoate

C26H42O5 (434.3032)

(1r,4as,5r,5's,8as)-5'-(2-methoxy-2-oxoethyl)-2,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5-ylmethyl 3-methylbutanoate

C26H42O5 (434.3032)

(1r,3r,3ar)-1,3-dihydroxy-1-isopropyl-3a,6-dimethyl-8-{[(2z)-2-methylbut-2-enoyl]oxy}-2,3,4,7,8,8a-hexahydroazulen-4-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)

(1s,2r,5r,10r,14s,16s,17r,20s,22r)-8-isopropyl-2,5-dimethyl-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricos-8-ene-14,17,21-triol

C25H38O6 (434.2668)

2-[n,3-dimethyl-2-(methylamino)butanamido]-n-[2-(1h-indol-3-yl)ethyl]-3-phenylpropanimidic acid

C26H34N4O2 (434.2682)

1-[(4ar,8s,8ar)-8,8a-dimethyl-3-{[(5s)-3,4,5-trimethyl-5h,6h,7h,8h-naphtho[2,3-b]furan-2-yl]oxy}-4,4a,5,6,7,8-hexahydro-1h-naphthalen-2-yl]ethanone

C29H38O3 (434.2821)

12,14-dihydroxy-5,9-dimethyl-14-{[(2-methylbut-2-enoyl)oxy]methyl}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

C25H38O6 (434.2668)

6,6'-dimethyl-3,3'-bis(6-methylhept-5-en-2-yl)-[1,1'-biphenyl]-2,2'-diol

C30H42O2 (434.3185)

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[(3r,6e,11s)-2,11,12-trihydroxy-2,6-dimethyl-10-methylidenedodec-6-en-3-yl]oxy}oxane-3,4,5-triol

C21H38O9 (434.2516)

[(3s,6s)-6-[(2s,5s)-5-[(9z,11z)-hexadeca-9,11,15-trien-1-yl]oxolan-2-yl]-1,2-dioxan-3-yl]acetic acid

C26H42O5 (434.3032)

(2s)-3-[(1s,2r,4as,4bs,8as,10ar)-2,4a,4b,8,8a,10a-hexamethyl-1,2,3,4,5,6,9,10-octahydrophenanthrene-1-carbonyloxy]-2-hydroxypropyl acetate

C26H42O5 (434.3032)

[(3s,6s)-6-[(2s,5r)-5-[(9e,11e)-hexadeca-9,11,15-trien-1-yl]oxolan-2-yl]-1,2-dioxan-3-yl]acetic acid

C26H42O5 (434.3032)

2-[(6as,7r,10ar)-6,6,9-trimethyl-2-[2-(methylamino)ethyl]-6ah,7h,10h,10ah-benzo[c]isochromen-7-yl]-4-[2-(methylamino)ethyl]phenol

C28H38N2O2 (434.2933)

(3r,4s,6e,8e,10s)-2,10-dihydroxy-2,6,10-trimethyl-3-{[(2e)-2-methylbut-2-enoyl]oxy}dodeca-6,8,11-trien-4-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)

(2s,3z,12bs)-3-ethylidene-2-{3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C29H30N4 (434.247)

[(1r,2s,5s,7s,9r,11s,13r)-5-ethenyl-1,5,7,12,12-pentamethyl-11-{[(2z)-2-methylbut-2-enoyl]oxy}-6,8-dioxatricyclo[7.4.0.0²,⁷]tridecan-13-yl]acetic acid

C25H38O6 (434.2668)

(1r,3r,4r,4as,7s,8s,8as)-7,8-dihydroxy-3,4,8,8a-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-1h-naphthalen-1-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)

(1s,3s,3ar,4r,5r,7ar)-3,4-diethyl-5-[(1e,3e)-2-ethyl-4-phenylbuta-1,3-dien-1-yl]-1,5,7-trimethyl-2-oxo-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C29H38O3 (434.2821)

(1r,2s,4s,5s,6s,7r,8s,9r)-6-hydroxy-3,3,7,9-tetramethyl-5-{[(2r)-2-methylbutanoyl]oxy}-11-oxotricyclo[5.4.0.0²,⁸]undecan-4-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)

(4bs,8as,10s)-10-{[4-(2-hydroxypropan-2-yl)phenyl]methyl}-2-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-3-ol

C30H42O2 (434.3185)

{6-[(2-hydroxy-3-methylbutanoyl)oxy]-5,8a-dimethyl-2-methylidene-5-(4-methylpent-3-en-1-yl)-hexahydro-1h-naphthalen-1-yl}acetic acid

C26H42O5 (434.3032)

5'-(2-methoxy-2-oxoethyl)-2,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5-ylmethyl 2-methylbutanoate

C26H42O5 (434.3032)

(2s)-2-[(1r,2r,3s,4s,6e,10s)-2-hydroxy-6,10-dimethyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}-11-oxabicyclo[8.1.0]undec-6-en-3-yl]propyl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)

2-{[1-hydroxy-3,8-dimethyl-5-(6-methylhept-5-en-2-yl)-5,6,7,8-tetrahydronaphthalen-2-yl]oxy}oxane-3,4,5-triol

C25H38O6 (434.2668)

1-[1-(4-methoxy-3-methylidene-4-oxobutyl)-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl 4-methyl butanedioate

C25H38O6 (434.2668)

methyl 11-(butanoyloxy)-1,1,4a-trimethyl-8-oxo-dodecahydrophenanthro[1,10a-c]furan-7-carboxylate

C25H38O6 (434.2668)

(2r,3r,3ar,4s,7s,7ar)-7,7a-dimethyl-4-{[(2r)-2-methylbutanoyl]oxy}-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

C25H38O6 (434.2668)